(Q37201622)

18 August 2017

1 reference

title

The Renin Academy Summit: advancing the understanding of renin science (English)

1 reference

18 August 2017

Ah Jan Danser

1

1 reference

18 August 2017

Genevieve Nguyen

series ordinal

2

1 reference

18 August 2017

language of work or name

1 reference

1 June 2008

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

18 August 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 August 2017

volume

9

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

119-123

1 reference

Elevated blood pressure and heart rate in human renin receptor transgenic rats.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Molecular Analysis of Human Prorenin Prosegment Variants in Vitro and in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Non-proteolytic activation of prorenin: activation by (pro)renin receptor and its inhibition by a prorenin prosegment, "decoy peptide".

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Direct renin inhibition with aliskiren in hypertension and target organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Renin inhibition with aliskiren: where are we now, and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2008.020

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2008.020

1 reference

18 August 2017

1 reference